BORRELLI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 2.521
AS - Asia 1.930
NA - Nord America 1.683
SA - Sud America 396
AF - Africa 49
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.595
Nazione #
US - Stati Uniti d'America 1.592
RU - Federazione Russa 1.540
CN - Cina 657
SG - Singapore 582
BR - Brasile 326
IT - Italia 306
VN - Vietnam 239
SE - Svezia 233
HK - Hong Kong 204
FR - Francia 113
IN - India 80
DE - Germania 73
GB - Regno Unito 70
CA - Canada 54
FI - Finlandia 51
MX - Messico 29
NL - Olanda 28
PL - Polonia 28
JP - Giappone 27
AR - Argentina 25
ES - Italia 21
TR - Turchia 19
ZA - Sudafrica 19
IQ - Iraq 18
BD - Bangladesh 17
KR - Corea 15
ID - Indonesia 12
LT - Lituania 12
AT - Austria 11
CO - Colombia 11
NZ - Nuova Zelanda 11
BE - Belgio 10
PY - Paraguay 10
IE - Irlanda 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
VE - Venezuela 6
PK - Pakistan 5
AU - Australia 4
DZ - Algeria 4
IL - Israele 4
PH - Filippine 4
TN - Tunisia 4
CL - Cile 3
CR - Costa Rica 3
KE - Kenya 3
NP - Nepal 3
TH - Thailandia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
RO - Romania 2
RS - Serbia 2
SD - Sudan 2
SN - Senegal 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 6.595
Città #
Singapore 353
Ashburn 351
Moscow 300
San Jose 196
Hong Kong 194
Shanghai 131
Beijing 129
Dallas 120
New York 110
Hefei 85
Ho Chi Minh City 83
Lauterbourg 74
Los Angeles 74
Milan 63
Hanoi 62
Lawrence 57
Princeton 57
São Paulo 36
Helsinki 29
Santa Clara 26
Chennai 25
Orem 25
Warsaw 25
Tokyo 24
Montreal 23
Brooklyn 19
Poplar 18
Council Bluffs 17
London 17
Boardman 16
Johannesburg 16
Phoenix 16
Toronto 16
Atlanta 15
Mumbai 15
Ludhiana 14
Rome 14
Houston 13
Chicago 12
Denver 12
Gwanak-gu 12
Novlyanka 12
Nuremberg 12
Stockholm 12
Mexico City 11
Turku 11
Amsterdam 10
Ankara 10
Auckland 10
Boston 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Manchester 10
Shenzhen 10
Biên Hòa 9
Dublin 9
Hải Dương 9
Munich 9
Rio de Janeiro 9
The Dalles 9
Brussels 8
Trento 8
Asunción 7
Belo Horizonte 7
Haiphong 7
Vienna 7
Bari 6
Barnet 6
Brasília 6
Cesano Boscone 6
Hanover 6
Jakarta 6
Kuala Lumpur 6
Naples 6
Ninh Bình 6
Piracicaba 6
San Francisco 6
San Giovanni la Punta 6
Seattle 6
Tianjin 6
Baghdad 5
Bergamo 5
Brescia 5
Dhaka 5
Porto Alegre 5
Querétaro 5
Riyadh 5
Thái Nguyên 5
Zhengzhou 5
Catania 4
Contagem 4
Curitiba 4
Da Nang 4
Dubai 4
Duque de Caxias 4
Itaquaquecetuba 4
Lahore 4
Montes Claros 4
Monza 4
Totale 3.309
Nome #
OCULAR AND GENETIC CHARACTERISTICS OF PATIENTS SURVIVING LONG-LASTING TYPE 1 DIABETES WITHOUT VASCULAR COMPLICATIONS 173
Perifoveal exudative vascular anomalous complex in a highly myopic eye 135
Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in patients with acute Leber's hereditary optic neuropathy 124
CHOROIDAL VASCULARITY INDEX IN HYDROXYCHLOROQUINE TOXIC RETINOPATHY: A Quantitative Comparative Analysis Using Enhanced Depth Imaging In Spectral Domain Optical Coherence Tomography 116
Long-term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes with Diabetic Macular Edema treated with Anti-VEGF Therapy 115
Retinal neurodegeneration in age-related macular degeneration 107
Visual Outcomes and Optical Coherence Tomography Biomarkers of Vision Improvement in Patients With Leber Hereditary Optic Neuropathy Treated With Idebenone 107
Choroidal vascularity index in leptochoroid: A comparative analysis between reticular pseudodrusen and high myopia 105
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study 104
Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion 102
Photoreceptor alteration in intermediate age-related macular degeneration 101
Choroidal vascularity index is associated with geographic atrophy progression 100
Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease 99
Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss 98
Choroidal Rift: A New OCT Finding in Eyes with Central Serous Chorioretinopathy 95
Choroidal cleft simulating choroidal caverns in neovascular age-related macular degeneration 94
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 94
Choroidal vascularity index in hereditary optic neuropathies 91
Choroidal Neovascularization in a Patient with Crohn's Disease 89
Choroideremia: Update On Clinical Features And Emerging Treatments 89
CHOROIDAL AMYLOID DEPOSITION: A Multicenter Study of Amyloid Lesions Identified in Late Indocyanine Green Angiography 88
Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema 88
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy 88
Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine 87
Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema 86
Longitudinal follow-up and outcome analysis in central serous chorioretinopathy 86
In vivo rotational three-dimensional OCTA analysis of microaneurysms in the human diabetic retina 85
Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect” 85
Complications associated with worse visual outcomes in patients with exudative neovascular age-related macular degeneration 85
Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration 83
Choroidal luminal and stromal areas and choriocapillaris perfusion are characterised by a non-linear quadratic relation in healthy eyes 83
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices 83
Changes in Choroidal Thickness follow the RNFL Changes in Leber’s Hereditary Optic Neuropathy 82
Gliotic tissue simulating a macular neovascularization in full-thickness macular hole 82
Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy? 82
Choroidal thickness and the retinal ganglion cell complex in chronic Leberʼs hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography 81
Comparison Between Ultra-Widefield Pseudocolor Imaging and Indirect Ophthalmoscopy in the Detection of Peripheral Retinal Lesions 80
OCT-A characterisation of recurrent type 3 macular neovascularisation 79
Multimodal imaging characterization of peripheral drusen 79
Diabetic macular ischemia 78
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic 78
Prevalence and Morphologic Biomarkers of Metamorphopsia in eyes with "Resolved" Chronic Central Serous Chorioretinopathy 77
Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy 76
Longitudinal evaluation of the development of wedge-shaped subretinal hyporeflectivity in geographic atrophy 76
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study 76
Nonmydriatic widefield retinal imaging with an automatic white LED confocal imaging system compared with dilated ophthalmoscopy in screening for diabetic retinopathy 76
Multimodal Imaging of Peripapillary hyperreflective ovoid mass-like structures (PHOMS) 75
Spectrally Resolved Fundus Autofluorescence in Healthy Eyes: Repeatability and Topographical Analysis of the Green-Emitting Fluorophores 74
Complicated Retinal Pigment Epithelium Humps in High Myopia 72
Recognition, diagnosis and treatment of chorioretinal folds: Current perspectives 72
Dimple in vascularized serous pigment epithelial detachment secondary to neovascular age-related macular degeneration 72
INNER AND OUTER CHOROIDAL CHANGES IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 71
Nonexudative Perifoveal Vascular Anomalous Complex: The Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 70
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction 69
Spontaneous resolution of optic pit maculopathy: an OCT report 69
Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography 69
Guidelines on Optical Coherence Tomography Angiography Imaging: 2020 Focused Update 66
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 65
Peripapillary hyperreflective ovoid mass-like structures (PHOMS): OCTA may reveal new findings 65
Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease 63
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy 63
Quantification of diabetic macular ischemia using novel three-dimensional optical coherence tomography angiography metrics 62
Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy 61
TriPla Regimen: A new treatment approach for patients with neovascular age-related macular degeneration in the COVID-19 "era" 61
Management of patients with diabetic macular oedema and good visual acuity: new findings from Protocol V 58
Emerging therapies in the management of macular edema: A review [version 1; peer review: 2 approved] 58
Quantitative Analysis of Choriocapillaris Using Swept-Source Optical Coherence Tomography Angiography in Eyes with Angioid Streaks 57
Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization 57
Impact of bleaching on photoreceptors in different intermediate AMD phenotypes 56
InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years 55
Multimodal imaging to detect in vivo responses to aflibercept therapy in a mouse model of type 3 neovascularization 55
Imaging Biomarkers of Mesopic and Dark-Adapted Macular Functions in Eyes With Treatment-Naïve Mild Diabetic Retinopathy 53
Morphofunctional analysis of the retina in patients with type 1 diabetes without complications after 30 years of disease 53
Neovascular age-related macular degeneration: advancement in retinal imaging builds a bridge between histopathology and clinical findings 52
PHOTORECEPTOR OUTER SEGMENT IS EXPANDED IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 52
Reply to: Non-Exudative Perifoveal Vascular Anomalous Complex: the Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 52
Subretinal pseudocysts: A novel OCT finding in diabetic macular edema 52
Haller’s vessels patterns in non-neovascular age-related macular degeneration 51
Predictors of Macular Atrophy after Serous Pigment Epithelial Detachment Collapse in Type 3 Macular Neovascularization and Age-Related Macular Degeneration 50
Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported Symptoms 50
Management of patients with macular oedema secondary to central retinal vein occlusion: new findings from SCORE2 and LEAVO studies 50
Choroidal Hyperreflective Foci Represent a Common Finding Across Different Types of Macular Atrophy 49
Optical coherence tomography angiography in diabetes: focus on microaneurysms 49
Retinal Telangiectasias Associated with Myelinated Nerve Fibers 47
Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy 47
Optical coherence tomography angiography in diabetes: A review 45
Structural reorganization of the ophthalmological practice in a COVID-19 hub hospital: experience from European epicenter of the pandemic 44
Visual Performance and Predictive OCT Biomarkers in Epiretinal Membrane Assessment: Beyond Distance Visual Acuity 19
Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD 8
Deep Learning in Neovascular Age-Related Macular Degeneration 8
Pushing Retinal Imaging Forward: Innovations and their Clinical Meaning. The 2022 Ophthalmologica Lecture 8
OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD 6
Intersession repeatability of reading performance measures in patients with neovascular age-related macular degeneration 5
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management 5
Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD 5
The “triple-layer sign”: an optical coherence tomography signature for the detection of non-exudative macular neovascularization 5
Sectorial Ganglion Cell Complex Thickness as Biomarker of Vision Outcome in Patients With Dominant Optic Atrophy 5
Relationship of Topographic Distribution of Macular Atrophy Secondary to Neovascular AMD and Reading Performance 5
Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial 4
Validation of a deep learning model for automatic detection and quantification of five OCT critical retinal features associated with neovascular age-related macular degeneration 4
Totale 6.765
Categoria #
all - tutte 37.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202278 0 0 0 35 10 1 9 8 2 0 4 9
2022/2023423 136 95 29 8 1 46 12 22 40 19 4 11
2023/2024550 9 45 46 117 56 120 22 37 7 29 29 33
2024/20251.325 163 67 47 38 103 140 165 123 130 119 92 138
2025/20264.355 325 338 191 538 431 141 469 368 1.306 248 0 0
Totale 6.780